871 related articles for article (PubMed ID: 23780386)
21. Tetramethylpyrazine-2'-O-sodium ferulate attenuates blood-brain barrier disruption and brain oedema after cerebral ischemia/reperfusion.
Xu SH; Yin MS; Liu B; Chen ML; He GW; Zhou PP; Cui YJ; Yang D; Wu YL
Hum Exp Toxicol; 2017 Jul; 36(7):670-680. PubMed ID: 27387348
[TBL] [Abstract][Full Text] [Related]
22. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
Li P; Mao L; Liu X; Gan Y; Zheng J; Thomson AW; Gao Y; Chen J; Hu X
Stroke; 2014 Mar; 45(3):857-64. PubMed ID: 24496394
[TBL] [Abstract][Full Text] [Related]
23. IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
Niu F; Song XY; Hu JF; Zuo W; Kong LL; Wang XF; Han N; Chen NH
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2065-2073. PubMed ID: 28669655
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.
Yang Y; Salayandia VM; Thompson JF; Yang LY; Estrada EY; Yang Y
J Neuroinflammation; 2015 Feb; 12():26. PubMed ID: 25889169
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
[TBL] [Abstract][Full Text] [Related]
26. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats.
Shimamura N; Matchett G; Solaroglu I; Tsubokawa T; Ohkuma H; Zhang J
J Neurosci Res; 2006 Dec; 84(8):1837-47. PubMed ID: 17016855
[TBL] [Abstract][Full Text] [Related]
28. Acceleration of collateral development by carcinoembryonic antigen-related cell adhesion molecule 1 expression on CD11b/⁺Gr-1⁺ myeloid cells--brief report.
Bickert T; Marshall RP; Zhang Z; Ludewig P; Binder M; Klinke A; Rottbauer W; Amling M; Wagener C; Ito WD; Horst AK
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2566-8. PubMed ID: 22962327
[TBL] [Abstract][Full Text] [Related]
29. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
Kamada H; Yu F; Nito C; Chan PH
Stroke; 2007 Mar; 38(3):1044-9. PubMed ID: 17272778
[TBL] [Abstract][Full Text] [Related]
30. Monocyte chemoattractant protein-1-deficiency results in altered blood-brain barrier breakdown after experimental stroke.
Strecker JK; Minnerup J; Schütte-Nütgen K; Gess B; Schäbitz WR; Schilling M
Stroke; 2013 Sep; 44(9):2536-44. PubMed ID: 23821228
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin in traumatic brain injury: effect on brain edema mechanisms.
Béziaud T; Ru Chen X; El Shafey N; Fréchou M; Teng F; Palmier B; Beray-Berthat V; Soustrat M; Margaill I; Plotkine M; Marchand-Leroux C; Besson VC
Crit Care Med; 2011 Oct; 39(10):2300-7. PubMed ID: 21666443
[TBL] [Abstract][Full Text] [Related]
32. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
33. ICAM-1
Enzmann GU; Pavlidou S; Vaas M; Klohs J; Engelhardt B
Transl Stroke Res; 2018 Dec; 9(6):608-621. PubMed ID: 29399739
[TBL] [Abstract][Full Text] [Related]
34. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
35. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E
Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273
[TBL] [Abstract][Full Text] [Related]
36. Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Jang JW; Lee JK; Hur H; Kim TW; Joo SP; Piao MS
J Neurol Sci; 2014 Apr; 339(1-2):75-80. PubMed ID: 24507948
[TBL] [Abstract][Full Text] [Related]
37. Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke.
Jin AY; Tuor UI; Rushforth D; Kaur J; Muller RN; Petterson JL; Boutry S; Barber PA
BMC Neurosci; 2010 Feb; 11():12. PubMed ID: 20122276
[TBL] [Abstract][Full Text] [Related]
38. Buyang Huanwu Decoction Attenuates Infiltration of Natural Killer Cells and Protects Against Ischemic Brain Injury.
Dou B; Zhou W; Li S; Wang L; Wu X; Li Y; Guan H; Wang C; Zhu S; Ke Z; Huang C; Wang Z
Cell Physiol Biochem; 2018; 50(4):1286-1300. PubMed ID: 30355926
[TBL] [Abstract][Full Text] [Related]
39. Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.
Ritzel RM; Pan SJ; Verma R; Wizeman J; Crapser J; Patel AR; Lieberman R; Mohan R; McCullough LD
Mol Vis; 2016; 22():575-88. PubMed ID: 27293375
[TBL] [Abstract][Full Text] [Related]
40. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury.
Chehaibi K; le Maire L; Bradoni S; Escola JC; Blanco-Vaca F; Slimane MN
Transl Res; 2017 Apr; 182():27-48. PubMed ID: 27818230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
